Integrated BioPharma, Inc. (INBP)
USD 0.32
(0.0%)
USD 0.32
(0.0%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 943 Thousand | 1.23 Million | 4.09 Million | 3.05 Million | 1.33 Million | 328 Thousand |
| Net Income | 112 Thousand | -34 Thousand | 3.83 Million | 8.01 Million | 4.1 Million | 1.68 Million |
| Depreciation & Amortization | 1.22 Million | 1.15 Million | 834 Thousand | 826 Thousand | 772 Thousand | 774 Thousand |
| Deferred income taxes | 125 Thousand | 72 Thousand | -1.53 Million | -1.38 Million | -1.34 Million | 33 Thousand |
| Stock-based compensation | 252 Thousand | 320 Thousand | 369 Thousand | 231 Thousand | 59 Thousand | 144 Thousand |
| Change in working capital | -744 Thousand | -302 Thousand | 565 Thousand | -3.04 Million | -2.1 Million | -2.43 Million |
| Other non-cash items | 12 Thousand | 22 Thousand | 15 Thousand | -1.58 Million | -142 Thousand | 119 Thousand |
| Investing Cash Flow | -553 Thousand | -111 Thousand | -465 Thousand | -199 Thousand | -110 Thousand | -422 Thousand |
| Investments in PPE | -553 Thousand | -116 Thousand | -486 Thousand | -295 Thousand | -214 Thousand | -414 Thousand |
| Acquisitions | - | 4000.00 | 21 Thousand | 96 Thousand | 101 Thousand | -8000.00 |
| Investment purchases | - | -4000.00 | - | -192 Thousand | - | -8000.00 |
| Sales/Maturities of investments | - | 4000.00 | - | 96 Thousand | 101 Thousand | 16 Thousand |
| Other Investing Activities | - | 1000.00 | 21 Thousand | 96 Thousand | -98 Thousand | -8000.00 |
| Financing Cash Flow | -29 Thousand | -136 Thousand | -3.5 Million | -3.04 Million | -1.3 Million | 341 Thousand |
| Debt repayment | -42 Thousand | -136 Thousand | -58.15 Million | -60.72 Million | -50.16 Million | -51.25 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 13 Thousand | 4000.00 | 34 Thousand | 96 Thousand | 101 Thousand | 24 Thousand |
| Other Financing Activities | 13 Thousand | -4000.00 | 54.61 Million | 57.58 Million | 48.75 Million | 51.57 Million |
| Accounts receivables | -120 Thousand | 374 Thousand | 927 Thousand | -294 Thousand | -1.08 Million | -593 Thousand |
| Accounts payables | 244 Thousand | -921 Thousand | -218 Thousand | -937 Thousand | 487 Thousand | -329 Thousand |
| Inventory | -983 Thousand | 794 Thousand | 640 Thousand | -1.59 Million | -1.28 Million | -1.07 Million |
| Other working capital | 115 Thousand | -247 Thousand | -784 Thousand | -221 Thousand | -232 Thousand | -431 Thousand |
| Cash at beginning of period | 1.31 Million | 331 Thousand | 210 Thousand | 402 Thousand | 475 Thousand | 228 Thousand |
| Cash at end of period | 1.67 Million | 1.31 Million | 331 Thousand | 210 Thousand | 402 Thousand | 475 Thousand |
| Capital Expenditure | -553 Thousand | -116 Thousand | -486 Thousand | -295 Thousand | -214 Thousand | -414 Thousand |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | 361 Thousand | 985 Thousand | 121 Thousand | -192 Thousand | -73 Thousand | 247 Thousand |
| Free Cash Flow | 390 Thousand | 1.11 Million | 3.6 Million | 2.75 Million | 1.12 Million | -86 Thousand |
| Breakdown | 2024 Q4 | 2024 FY | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 268 Thousand | 112 Thousand | 285 Thousand | 58.55 Thousand | -59 Thousand | -34 Thousand |
| Depreciation & Amortization | 317 Thousand | 1.22 Million | 304 Thousand | -297.4 Thousand | 298 Thousand | 1.15 Million |
| Deferred income taxes | 113 Thousand | 125 Thousand | 80 Thousand | -8068.00 | 8000.00 | 72 Thousand |
| Stock-based compensation | 59 Thousand | 252 Thousand | 192.86 Thousand | -70.86 Thousand | 71 Thousand | 320 Thousand |
| Change in working capital | -910 Thousand | - | 912 Thousand | -992.74 Thousand | 992 Thousand | -302 Thousand |
| Other non-cash items | 2000.00 | - | 371 Thousand | -2992.00 | 3000.00 | 22 Thousand |
| Investing Cash Flow | -146 Thousand | -553 Thousand | -345 Thousand | 37.93 Thousand | -38 Thousand | -111 Thousand |
| Investments in PPE | -146 Thousand | -553 Thousand | -345 Thousand | 37.93 Thousand | -38 Thousand | -116 Thousand |
| Acquisitions | - | - | - | - | - | 4000.00 |
| Investment purchases | - | - | - | - | - | -4000.00 |
| Sales/Maturities of investments | - | - | - | - | - | 4000.00 |
| Other Investing Activities | - | - | - | - | - | 1000.00 |
| Financing Cash Flow | -11 Thousand | -29 Thousand | -10 Thousand | -3008.00 | 3000.00 | -136 Thousand |
| Debt repayment | -11 Thousand | -42 Thousand | -10 Thousand | -9979.00 | -10 Thousand | -136 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | 13 Thousand | 4000.00 |
| Other Financing Activities | - | 13 Thousand | - | 6971.00 | 13 Thousand | -4000.00 |
| Accounts receivables | 86 Thousand | -120 Thousand | -984 Thousand | -338.22 Thousand | 339 Thousand | 374 Thousand |
| Accounts payables | -1.09 Million | 244 Thousand | 303 Thousand | -1.24 Million | 1.25 Million | -921 Thousand |
| Inventory | -75 Thousand | -983 Thousand | 980 Thousand | 248.11 Thousand | -250 Thousand | 794 Thousand |
| Other working capital | 177 Thousand | - | 613 Thousand | 347.32 Thousand | -1.34 Million | -247 Thousand |
| Cash at beginning of period | 2.02 Million | 1.31 Million | 732 Thousand | 2.59 Million | 1.31 Million | 331 Thousand |
| Cash at end of period | 1.67 Million | 1.67 Million | 2.02 Million | 732.00 | 2.59 Million | 1.31 Million |
| Capital Expenditure | -146 Thousand | -553 Thousand | -345 Thousand | 37.93 Thousand | -38 Thousand | -116 Thousand |
| Effect of forex changes on cash | - | - | - | -1.31 Million | - | - |
| Net cash flow / Change in cash | -343 Thousand | 361 Thousand | 1.28 Million | -2.59 Million | 1.27 Million | 985 Thousand |
| Free Cash Flow | -332 Thousand | 390 Thousand | 1.29 Million | -1.27 Million | 1.27 Million | 1.11 Million |
AXIS
3581
TRNR
VIVA3
9692
5724